FI971227L - Pyramidinyylipyratsolijohdannaisia - Google Patents

Pyramidinyylipyratsolijohdannaisia Download PDF

Info

Publication number
FI971227L
FI971227L FI971227A FI971227A FI971227L FI 971227 L FI971227 L FI 971227L FI 971227 A FI971227 A FI 971227A FI 971227 A FI971227 A FI 971227A FI 971227 L FI971227 L FI 971227L
Authority
FI
Finland
Prior art keywords
pyramidinylpyrazole
derivatives
pyramidinylpyrazole derivatives
Prior art date
Application number
FI971227A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI971227A7 (fi
FI971227A0 (fi
Inventor
Akio Ejima
Masamichi Sugimori
Ikuo Mitsui
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of FI971227A0 publication Critical patent/FI971227A0/fi
Publication of FI971227L publication Critical patent/FI971227L/fi
Publication of FI971227A7 publication Critical patent/FI971227A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI971227A 1994-09-26 1995-09-25 Pyramidinyylipyratsolijohdannaisia FI971227A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22942294 1994-09-26
JP13501095 1995-06-01
PCT/JP1995/001934 WO1996010024A1 (fr) 1994-09-26 1995-09-25 Derive pyrimidinylpyrazole

Publications (3)

Publication Number Publication Date
FI971227A0 FI971227A0 (fi) 1997-03-24
FI971227L true FI971227L (fi) 1997-05-23
FI971227A7 FI971227A7 (fi) 1997-05-23

Family

ID=26468965

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971227A FI971227A7 (fi) 1994-09-26 1995-09-25 Pyramidinyylipyratsolijohdannaisia

Country Status (13)

Country Link
US (1) US5852019A (enEXAMPLES)
EP (1) EP0784055B1 (enEXAMPLES)
KR (1) KR100388568B1 (enEXAMPLES)
CN (1) CN1071754C (enEXAMPLES)
AT (1) ATE232528T1 (enEXAMPLES)
CA (1) CA2201110A1 (enEXAMPLES)
DE (2) DE69529619D1 (enEXAMPLES)
DK (1) DK0784055T3 (enEXAMPLES)
ES (1) ES2192584T3 (enEXAMPLES)
FI (1) FI971227A7 (enEXAMPLES)
NO (1) NO313196B1 (enEXAMPLES)
TW (1) TW312694B (enEXAMPLES)
WO (1) WO1996010024A1 (enEXAMPLES)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169086B1 (en) 1997-01-27 2001-01-02 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
ID22017A (id) * 1997-01-27 1999-08-26 Daiichi Seiyaku Co Turunan-turunan pirazol
CN1320122A (zh) * 1998-07-24 2001-10-31 第一制药株式会社 吡唑衍生物及其盐
JP4709388B2 (ja) * 1999-01-25 2011-06-22 全薬工業株式会社 複素環式化合物及びそれを有効成分とする抗腫瘍剤
CA2445395C (en) * 2001-04-27 2010-03-30 Zenyaku Kogyo Kabushiki Kaisha Heterocyclic compound and antitumor agent comprising the same as effective component
WO2003011837A1 (en) * 2001-08-01 2003-02-13 Merck & Co., Inc. Tyrosine kinase inhibitors
MXPA05008099A (es) * 2003-01-28 2005-09-21 Aventis Pharma Sa Productos n-aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
FR2850379B1 (fr) * 2003-01-28 2006-11-17 Aventis Pharma Sa Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
US20050130989A1 (en) * 2003-01-28 2005-06-16 Aventis Pharma S. A. N-arylheteroaromatic products compositions containing them and use thereof
US7223759B2 (en) * 2003-09-15 2007-05-29 Anadys Pharmaceuticals, Inc. Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds
WO2005095389A1 (ja) * 2004-03-31 2005-10-13 Zenyaku Kogyo Kabushiki Kaisha 複素環式化合物及びそれを有効成分とする抗悪性腫瘍剤
AU2006221285B2 (en) * 2005-03-11 2011-03-31 Zenyaku Kogyo Kabushikikaisha Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
US20070244110A1 (en) * 2006-04-14 2007-10-18 Zenyaku Kogyo Kabushiki Kaisha Treatment of prostate cancer, melanoma or hepatic cancer
MX2009003821A (es) 2006-10-10 2009-05-25 Amgen Inc Compuestos de n-aril pirazol para usarse contra la diabetes.
EP3285581B1 (en) * 2015-03-26 2021-08-11 Merck Sharp & Dohme Corp. Pyrazolyl pyrimidinone compounds as pde2 inhibitors
EP3356345B1 (en) 2015-09-30 2023-11-08 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Heteroaryl derivatives as sepiapterin reductase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3778433A (en) * 1969-04-18 1973-12-11 Sumitomo Chemical Co Process for producing benzodiazepine derivatives
JPS4842072A (enEXAMPLES) * 1971-09-29 1973-06-19
JPS61129129A (ja) * 1984-11-28 1986-06-17 Kureha Chem Ind Co Ltd 抗腫瘍剤
US5102893A (en) * 1986-07-07 1992-04-07 Warner-Lambert Company Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis

Also Published As

Publication number Publication date
ES2192584T3 (es) 2003-10-16
TW312694B (enEXAMPLES) 1997-08-11
DE69529619D1 (en) 2003-03-20
NO971384D0 (no) 1997-03-24
EP0784055A1 (en) 1997-07-16
NO313196B1 (no) 2002-08-26
NO971384L (no) 1997-05-23
EP0784055A4 (en) 1998-01-07
CN1166833A (zh) 1997-12-03
EP0784055B1 (en) 2003-02-12
KR970706275A (ko) 1997-11-03
DE69529619T4 (de) 2005-01-27
ATE232528T1 (de) 2003-02-15
CA2201110A1 (en) 1996-04-04
FI971227A7 (fi) 1997-05-23
KR100388568B1 (ko) 2003-10-04
FI971227A0 (fi) 1997-03-24
CN1071754C (zh) 2001-09-26
DK0784055T3 (da) 2003-06-02
US5852019A (en) 1998-12-22
DE69529619T2 (de) 2003-12-18
HK1001396A1 (en) 1998-06-19
WO1996010024A1 (fr) 1996-04-04

Similar Documents

Publication Publication Date Title
FI954829L (fi) Aroyylipiperidiinijohdannaiset
NO952854D0 (no) 1-arylpyrimidin-derivater
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
ATE323682T1 (de) Aryl-pyrimidin-derivate
ATE261942T1 (de) 6-phenylpyridinderivate
NO981946D0 (no) Imidazoquinazolin-derivater
EP0708091A3 (en) Indoloyl-guanidines derivatives
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
DE69430587D1 (de) Pyrimidin-acyclonukleosid-derivate
BR9509793A (pt) Derivados de tiofeneno
FI971227L (fi) Pyramidinyylipyratsolijohdannaisia
FI960367L (fi) Uusia dialkoksipyridinyylibentsimidatsolijohdannaisia
EE9900182A (et) 2-metoksüfenüülpiperasiini derivaadid
DE69527786D1 (de) Diaminomethyliden-derivate
FI964853L (fi) Deasetoksitaksolijohdannaiset
NO970144L (no) Trifluormetylkinolinkarboksylsyre-derivat
DE59509209D1 (de) Diphenyloxazolin-derivate
DE69510792D1 (de) Naphtochinonderivate
FI955026L (fi) Alkyyli-5-metyylisulfonyylibentsoyyliguanidiinijohdannaisia
BR9509877A (pt) Novos derivados de pirimidinilóxi-e piridimidinilamino- etilfenil-dioxolano
FI965181A7 (fi) Polyalkoholi-peptidijohdannaiset
FI963122A7 (fi) Karbamoyylimetyyliureajohdannaiset
BR9506613A (pt) Derivados de feniltio-oxazolinas
BR9508450A (pt) Derivados de n-alcóxi-amidina
DK0755927T3 (da) Dimethylfurancarboxyanilidderivat